Prognostic significance of laterality in lung neuroendocrine tumors

• Published in: Endocrine 2022-06, Vol.76 (3), p.733-746
• Main Authors: La Salvia, Anna, Persano, Irene, Siciliani, Alessandra, Verrico, Monica, Bassi, Massimiliano, Modica, Roberta, Audisio, Alessandro, Zanata, Isabella, Trabalza Marinucci, Beatrice, Trevisi, Elena, Puliani, Giulia, Rinzivillo, Maria, Parlagreco, Elena, Baldelli, Roberto, Feola, Tiziana, Sesti, Franz, Razzore, Paola, Mazzilli, Rossella, Mancini, Massimiliano, Panzuto, Francesco, Volante, Marco, Giannetta, Elisa, Romero, Carmen, Appetecchia, Marialuisa, Isidori, Andrea, Venuta, Federico, Ambrosio, Maria Rosaria, Zatelli, Maria Chiara, Ibrahim, Mohsen, Colao, Annamaria, Brizzi, Maria Pia, García-Carbonero, Rocío, Faggiano, Antongiulio
• Format: Article
• Language: English
• Subjects: Age; Diabetes; Diagnosis; Endocrinology; Humanities and Social Sciences; Internal Medicine; Lungs; Medical prognosis; Medicine; Medicine & Public Health; Metastases; multidisciplinary; Necrosis; Neuroendocrine tumors; Original; Original Article; Parenchyma; Science; Survival
• ISSN: 1559-0100; 1355-008X; 1559-0100
• DOI: 10.1007/s12020-022-03015-w

Purpose: Well-differentiated lung neuroendocrine tumors (Lu-NET) are classified as typical (TC) and atypical (AC) carcinoids, based on mitotic counts and necrosis. However, prognostic factors, other than tumor node metastasis (TNM) stage and the histopathological diagnosis, are still lacking. The current study is aimed to identify potential prognostic factors to better stratify lung NET, thus, improving patients’ treatment strategy and follow-up. Methods: A multicentric retrospective study, including 300 Lung NET, all surgically removed, from Italian and Spanish Institutions. Results: Median age 61 years (13–86), 37.7% were males, 25.0% were AC, 42.0% were located in the lung left parenchyma, 80.3% presented a TNM stage I-II. Mitotic count was ≥2 per 10 high-power field (HPF) in 24.7%, necrosis in 13.0%. Median overall survival (OS) was 46.1 months (0.6–323), median progression-free survival (PFS) was 36.0 months (0.3–323). Female sex correlated with a more indolent disease (T1; N0; lower Ki67; lower mitotic count and the absence of necrosis). Left-sided primary tumors were associated with higher mitotic count and necrosis. At Cox-multivariate regression model, age, left-sided tumors, nodal (N) positive status and the diagnosis of AC resulted independent negative prognostic factors for PFS and OS. Conclusions: This study highlights that laterality is an independent prognostic factors in Lu-NETs, with left tumors being less frequent but showing a worse prognosis than right ones. A wider spectrum of clinical and pathological prognostic factors, including TNM stage, age and laterality is suggested. These parameters could help clinicians to personalize the management of Lu-NET.